Top

Published in:

Open Access 01-12-2021 | Parkinson's Disease | Correction

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

Authors: Chunni Zhu, Tina Bilousova, Samantha Focht, Michael Jun, Chris Jean Elias, Mikhail Melnik, Sujyoti Chandra, Jesus Campagna, Whitaker Cohn, Asa Hatami, Patricia Spilman, Karen Hoppens Gylys, Varghese John

Published in: Molecular Brain | Issue 1/2021

Excerpt

Following publication of the original article [1], it was noted that due to a typesetting mistake, an incorrect version of Additional file 1 (with regards to the reference numbering) was processed. …

Available only for authorised users

Zhu C, Bilousova T, Focht S, Jun M, Elias CJ, Melnik M, Chandra S, Campagna J, Cohn W, Hatami A, Spilman P, Gylys KH, John V. Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model. Mol Brain. 2021;14:70. https://doi.org/10.1186/s13041-021-00776-9.CrossRefPubMedPubMedCentral

Title: Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
Authors: Chunni Zhu
Tina Bilousova
Samantha Focht
Michael Jun
Chris Jean Elias
Mikhail Melnik
Sujyoti Chandra
Jesus Campagna
Whitaker Cohn
Asa Hatami
Patricia Spilman
Karen Hoppens Gylys
Varghese John
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Parkinson's Disease
Published in: Molecular Brain / Issue 1/2021
Electronic ISSN: 1756-6606
DOI: https://doi.org/10.1186/s13041-021-00816-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases

2-Pentadecyl-2-oxazoline ameliorates memory impairment and depression-like behaviour in neuropathic mice: possible role of adrenergic alpha2- and H3 histamine autoreceptors

Non-SUMOylated CRMP2 decreases NaV1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15

Correction to: Antibiotics-induced intestinal dysbacteriosis caused behavioral alternations and neuronal activation in different brain regions in mice

Similarities of developmental gene expression changes in the brain between human and experimental animals: rhesus monkey, mouse, Zebrafish, and Drosophila

AMPAkines potentiate the corticostriatal pathway to reduce acute and chronic pain